IKT Stock: More Upside for Inhibikase Therapeutics, Inc. (NASDAQ:IKT)? – Marketing Sentinel
Home  »  Business   »  IKT Stock: More Upside for Inhibikase Therapeutics...

IKT Stock: More Upside for Inhibikase Therapeutics, Inc. (NASDAQ:IKT)?

In the last trading session, 1,374,188 Inhibikase Therapeutics, Inc. (NASDAQ:IKT) shares changed hands as the company’s beta touched 0. With the company’s per share price at $2.9 changed hands at $0.01 or 0% during last session, the market valuation stood at $29.39 Million. IKT’s last price was a discount, traded about -306.9% off its 52-week high of $11.8. The share price had its 52-week low at $2.82, which suggests the last value was 2.76% up since then. When we look at Inhibikase Therapeutics, Inc.’s average trading volume, we note the 10-day average is 2.45 Million shares, with the 3-month average coming to 262.24 Million.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Analysts gave the Inhibikase Therapeutics, Inc. (IKT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 0. If we narrow down to specifics, the data shows that none out of 1 analysts rate the stock as a Sell, with a further none assigning it an Overweight rating. Of the remaining, none recommended IKT as a Hold, 1 felt it is a Buy and none rated the stock as Underweight.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Inhibikase Therapeutics, Inc. (NASDAQ:IKT) trade information

The consensus price target for the stock as assigned by Wall Street analysts is $15, meaning bulls need an upside of 417.24% from its current market value. According to analyst projections, IKT’s forecast low is $15 with $15 as the target high. To hit the forecast high, the stock’s price needs a +417.24% upsurge from its current level, while the stock would need to tank 417.24% for it to hit the projected low.

Inhibikase Therapeutics, Inc. (IKT) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 0%. The 2021 estimates are for Inhibikase Therapeutics, Inc. earnings to increase by 43.3%, but the outlook for the next 5-year period is at 0% per year.

Inhibikase Therapeutics, Inc. (NASDAQ:IKT)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 52.84% of Inhibikase Therapeutics, Inc. shares while 16.49% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 34.96%. There are 13 institutions holding the Inhibikase Therapeutics, Inc. stock share, with FMR, LLC the top institutional holder. As of Mar 30, 2021, the company held 0.99% of the shares, roughly 100Thousand IKT shares worth $601Thousand.

Zeke Capital Advisors LLC holds the second largest percentage of outstanding shares, with 0.19% or 18.8 Thousand shares worth $112.99 Thousand as of Mar 30, 2021.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Among Mutual Funds, the top two as of Mar 30, 2021 were Fidelity Select Portfolios – Biotechnology and 360 Funds-Timber Point Global Tactical Allocation Fd. With 100000 shares estimated at $601Thousand under it, the former controlled 0.99% of total outstanding shares. On the other hand, 360 Funds-Timber Point Global Tactical Allocation Fd held about 0.5% of the shares, roughly 50Thousand shares worth around $300.5 Thousand.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam